Fortress Biotech, Inc. 4
4 · AVENUE THERAPEUTICS, INC. · Filed Jan 6, 2026
Insider Transaction Report
Form 4
Fortress Biotech, Inc.
10% Owner
Transactions
- Award
COMMON STOCK, PAR VALUE $0.0001
2026-01-02+111,209→ 439,733 total
Footnotes (1)
- [F1]The Reporting Person is entitled to an annual dividend on its Class A Preferred Stock equal to 2.5% of the Issuer's fully diluted outstanding capitalization on December 31. 111,209 shares were granted by the Issuer to the reporting Person for the 2025 annual dividend.